A model for integrating molecular-based testing in transfusion services.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Blood transfusion = Trasfusione del sangue

• Publication date

  2015-09-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.2450/2015.0070-15PMID 26509823PMCID PMC5111386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Service

  2018cited by this paper
• Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype

  2015cited by this paper
• It's time to phase in RHD genotyping for patients with a serologic weak D phenotype

  2015cited by this paper
• How do we use molecular red blood cell antigen typing to supplement pretransfusion testing?

  2014influential reference
• Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients

  2013cited by this paper
• Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients

  2013cited by this paper
• Anti‐U‐like as an alloantibody in S−s−U− and S−s−U+var black people

  2012cited by this paper
• A novel RHCE*ce 48C, 733G allele with Nucleotide 941C in Exon 7 encodes an altered red blood cell e antigen

  2011cited by this paper
• RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.

  2010cited by this paper
• TRANSFUSION PRACTICE: Toward extended phenotype matching: a new operational paradigm for the transfusion service

  2009influential reference
• The potential of blood group genotyping for transfusion medicine practice

  2008cited by this paper
• Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time

  2008influential reference
• Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services.

  2008influential reference
• Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high‐throughput DNA analysis

  2007cited by this paper
• Partners for Life: the transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia

  2006cited by this paper
• How I manage donors and patients with a weak D phenotype

  2006cited by this paper
• The Charles Drew Program in Missouri: a description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease

  2006cited by this paper
• Transfusion support of patients with sickle cell disease at the Children’s Hospital of Philadelphia

  2006cited by this paper
• Do we need to be more concerned about weak D antigens?

  2005cited by this paper
• Weak D alleles express distinct phenotypes.

  2000cited by this paper
• The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype.

  2000cited by this paper
• Rh phenotype prediction by DNA typing and its application to practice

  1998cited by this paper
• Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals

  1995cited by this paper
• Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay

  1987cited by this paper
• Critical Re‐examination of the Specificity of Auto‐anti‐Rh Antibodies in Patients with a Positive Direct Antiglobulin Test

  1978cited by this paper

• Molecular advances in transfusion medicine: a narrative review

  2025cites this paper
• A rare case of Bm (Bweak) phenotype detected in a healthy blood donor from Eastern India

  2023cites this paper
• B subgroup detection in a small hospital transfusion service

  2021cites this paper
• Serologically Weak D-phenotype: Review and Interpretation of Blood Group RhD

  2020cites this paper
• Red Cell Transfusions in the Genomics Era.

  2019cites this paper
• Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

  2019cites this paper
• A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

  2019cites this paper
• ID CORE XT as a tool for molecular red blood cell typing

  2019cites this paper
• How do I incorporate red cell genotyping to improve chronic transfusion therapy?

  2019cites this paper
• Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

  2018cites this paper
• Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype

  2017influential citation
• Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype

  2017cites this paper
• Separation of multiple antibodies by adsorption with allogeneic red blood cells

  2017cites this paper
• An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system

  2015cites this paper